Death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway
Norway: Death rate from cardiomyopathy myocarditis endocarditis who ghe age was 1.78 in 2021. ▼ Falling
Death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway, 2000–2021
Source: Our World in Data.
Analysis
The most recent figure for death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway is 1.78, measured in 2021. That is the lowest value across all 22 years on record.
The figure is down 1.8% on the previous year and down 10.4% over ten years.
Over the whole period, death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway peaked at 2.65 in 2001 and was at its lowest, 1.78, in 2021.
Norway ranks 180th of 194 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 22 years of available data.
Death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 2.51 | — |
| 2001 | 2.65 | +5.6% |
| 2002 | 2.65 | -0.1% |
| 2003 | 2.36 | -11.0% |
| 2004 | 2.32 | -1.5% |
| 2005 | 2.39 | +2.7% |
| 2006 | 2.33 | -2.5% |
| 2007 | 2.16 | -6.9% |
| 2008 | 2.58 | +19.1% |
| 2009 | 2.12 | -17.7% |
| 2010 | 2.45 | +15.5% |
| 2011 | 1.99 | -18.8% |
| 2012 | 2.41 | +21.1% |
| 2013 | 2.46 | +2.3% |
| 2014 | 2.57 | +4.4% |
| 2015 | 2.44 | -5.2% |
| 2016 | 2.43 | -0.3% |
| 2017 | 2.4 | -1.2% |
| 2018 | 2.23 | -7.0% |
| 2019 | 2.36 | +5.5% |
| 2020 | 1.82 | -23.0% |
| 2021 | 1.78 | -1.8% |
Norway compared with similar countries
- Norway's 1.78 is below the median for high income countries, which is 4.31, 41% of the median. (63 countries reporting)
- Norway's 1.78 is below the median for Europe & Central Asia, which is 4.73, 38% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.41 | 2.12 | 2.65 | 10 |
| 2010s | 2.37 | 1.99 | 2.57 | 10 |
| 2020s | 1.8 | 1.78 | 1.82 | 2 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Un projection of annual infant deaths 12 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.217 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0238 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0617 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0251 units per person (2025)
Frequently asked questions
- What is death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway?
- Death rate from cardiomyopathy myocarditis endocarditis who ghe age in Norway was 1.78 in 2021, according to Our World in Data.
- What is the highest death rate from cardiomyopathy myocarditis endocarditis who ghe age recorded in Norway?
- The highest recorded value was 2.65 in 2001.
- What is the lowest death rate from cardiomyopathy myocarditis endocarditis who ghe age recorded in Norway?
- The lowest recorded value was 1.78 in 2021.
- How does Norway rank for death rate from cardiomyopathy myocarditis endocarditis who ghe age?
- Norway ranks 180th out of 194 countries with data for 2021.
- Is death rate from cardiomyopathy myocarditis endocarditis who ghe age rising or falling in Norway?
- Over the last ten years it is down 10.4%. The long-run trend across the full record is falling.
- Where does this Norway data come from?
- The figures come from Our World in Data, published as part of Death rate from cardiomyopathy myocarditis endocarditis who ghe age standardized. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (Our World in Data).